Cramer's 'Mad Money' Recap: Get Healthy With Triple-S

Hologic's Expansive Plans

With long-term visibility, great growth and a great balance sheet, Cramer told viewers Hologic (HOLX - Cramer's Take - Stockpickr), which he owns for his charitable trust, Action Alerts PLUS, is his type of company.

He welcomed Jack Cumming, Hologic's chief executive officer, to the show and asked him to give a sense of the company's recent merger with Cytyc.

Cumming said they closed on the acquisition on Oct. 22, and that they're a little bit ahead of schedule. Cytyc, he said, shares the same passion for women's health, so the companies are very much alike.

Concerning Hologic's recent $1.3 billion convertible bond offering, Cumming said the company plans to take the money from the offering and pay down its debt. "We loathe debt," he said, and it has been Hologic's policy not to have that much of it.

Compared to competitors, Cumming said he believes Hologic has a "pretty good" head start when it comes to products. The company, he said, came to market two years behind other companies and is now nine months ahead in the competition for digital mammography.

Cumming was enthusiastic about his company's growth prospects. "We believe that when you have nine No 1. products, you're expected to grow at a fantastic rate," Cumming said.

Critiquing Regis' Stocks

People need to look at the market with a long-term perspective, and not worry about the short-term affects of the Fed, Cramer said. To see just how the how the holidays are shaping up, he welcomed his next guest, Regis Philbin, to the show.